Tryptamine Attenuates Experimental Multiple Sclerosis Through Activation of Aryl Hydrocarbon Receptor
Tryptamine is a naturally occurring monoamine alkaloid which has been shown to act as an aryl hydrocarbon receptor (AHR) agonist. It is produced in large quantities from the catabolism of the essential amino acid tryptophan by commensal microorganisms within the gastrointestinal (GI) tract of homeot...
Saved in:
Main Authors: | Nicholas Dopkins (Author), William Becker (Author), Kathryn Miranda (Author), Mike Walla (Author), Prakash Nagarkatti (Author), Mitzi Nagarkatti (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019
by: Prakash Nagarkatti, et al.
Published: (2020) -
Editorial: Substance abuse and the microbiome
by: Prakash Nagarkatti, et al.
Published: (2024) -
Geographic inequality in funding by National Institutes of Health negatively impacts almost one-half of the states in the United States
by: Elizabeth Caulder, et al.
Published: (2024) -
Antioxidant Functions of the Aryl Hydrocarbon Receptor
by: Cornelia Dietrich
Published: (2016) -
Aryl Hydrocarbon Receptor and Stem Cells
by: Thomas A. Gasiewicz, et al.
Published: (2017)